The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration
Open accessAbstract
Background: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. Methods and Results: We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual countries. We explored patterns in relationships with age, sex, and income and calculated age-standardized mortality rates for each country in addition to crude death rates. In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lower respiratory tract diseases) and examined the simultaneous trends in important cardiovascular risk factors. Russia, United States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data. Among 5 illustrative countries (United Kingdom, United States, Brazil, Kazakhstan, and Ukraine), IHD was the top cause of death, but mortality from IHD has progressively decreased from 2005 to 2015. Age-standardized IHD mortality rates per 100 000 people per year were much higher in Ukraine (324) and Kazakhstan (97) than in United States (60), Brazil (54), and the United Kingdom (46), with much less difference in other causes of death. All 5 countries showed a progressive decline in IHD mortality, with a decline in smoking and hypertension and in all cases a rise in obesity and type II diabetes mellitus. Conclusions: IHD remains the single largest cause of death in countries of all income groups. Rates are different between countries and are falling in most countries, indicating great potential for further gains. On the horizon, future improvements may become curtailed by increasing hypertension in some developing countries and more importantly global growth in obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite advancements in clinical management, MI and ischemic cardiomyopathy are among the leading causes of heart failure, associated morbidity, and death worldwide 3,4 and continue to impose staggering financial burden on healthcare systems 3,5-8 .”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foreman, K. J., Marquez, N., Dolgert, A. J., Fukutaki, K. G., Fullman, N., McGaughey, M., Pletcher, M. A., Smith, A. E., Tang, K., Yuan, C.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31694-5 · Cited by 3,154
Use of mass media campaigns to change health behaviour
Wakefield, M. A., Loken, B., & Hornik, R. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60809-4 · Cited by 2,485
AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
Ahmad, O. B., Boschi-Pinto, C., López, A. D., Murray, C. J. L., Lozano, R., & Inoue, M. (2000) · Cited by 1,793
Global Health Observatory Data Repository
Vardell, E. (2020) · Medical Reference Services Quarterly · doi:10.1080/02763869.2019.1693231 · Cited by 1,575
Finegold, J. A., Asaria, P., & Francis, D. P. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.046 · Cited by 880
Self-citationThe Coronary Artery Disease (C4D) Genetics Consortium (2011) · Nature Genetics · doi:10.1038/ng.782 · Cited by 674
Cardiovascular Health in Brazil
Ribeiro, A. L. P., Duncan, B. B., Brant, L. C. C., Lotufo, P. A., Mill, J. G., & Barreto, S. M. (2016) · Circulation · doi:10.1161/circulationaha.114.008727 · Cited by 374
Steel, N., Ford, J. A., Newton, J. N., Davis, A. C., Vos, T., Naghavi, M., Glenn, S., Hughes, A. J., Dalton, A. M., Stockton, D., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32207-4 · Cited by 275
Nowbar, A. N., Howard, J. P., Finegold, J. A., Asaria, P., & Francis, D. P. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.096 · Cited by 157
Self-citationCentral Asia — twenty-five years after the breakup of the USSR
Batsaikhan, U., & Dąbrowski, M. (2017) · Russian Journal of Economics · doi:10.1016/j.ruje.2017.09.005 · Cited by 148
Cited by
Sorted by citations
Items 101–200 of 865
Boyd, C., Brown, G. C., Kleinig, T. J., Dawson, J. A., McDonnell, M. D., Jenkinson, M., & Bezak, E. (2021) · Diagnostics · doi:10.3390/diagnostics11030551 · Cited by 32
Revascularization in stable coronary artery disease
Al-Lamee, R. K., Foley, M. J., Rajkumar, C., & Francis, D. P. (2022) · BMJ · doi:10.1136/bmj-2021-067085 · Cited by 33
Self-citationD’Andrea, A., Sperlongano, S., Pacileo, M., Venturini, E., Iannuzzo, G., Gentile, M., Sperlongano, R., Vitale, G., Maglione, M., Cice, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103131 · Cited by 29
“primary prevention and improved diagnosis and treatment [1].”
BackgroundAssociation of Periodontal Status, Number of Teeth, and Obesity: A Cross-Sectional Study in Japan
Aoyama, N., Fujii, T., Kida, S., Nozawa, I., Taniguchi, K., Fujiwara, M., Iwane, T., Tamaki, K., & Minabe, M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020208 · Cited by 29
Scărlătescu, A. I., Barbălată, T., Sima, A. V., Stancu, C. S., Niculescu, L. S., & Micheu, M. M. (2022) · Diagnostics · doi:10.3390/diagnostics12081946 · Cited by 29
Cardiac Exosomes in Ischemic Heart Disease—A Narrative Review
Røsand, Ø., & Høydal, M. A. (2021) · Diagnostics · doi:10.3390/diagnostics11020269 · Cited by 28
Brinza, C., Floria, M., Covic, A. C., & Burlacu, A. (2021) · Medicina · doi:10.3390/medicina57101021 · Cited by 28
Christodoulou, A., Nikolaou, P., Symeonidi, L., Katogiannis, K., Pechlivani, L., Νίκου, Θ., Varela, A., Chania, C., Zerikiotis, S., Efentakis, P., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103311 · Cited by 28
“Cardiovascular diseases (CVDs) present a significant public health challenge, as they remain the leading cause of morbidity and mortality worldwide [1].”
BackgroundBrugada Syndrome as a Major Cause of Sudden Cardiac Death in Asians
Nakano, Y., & Shimizu, W. (2022) · JACC Asia · doi:10.1016/j.jacasi.2022.03.011 · Cited by 29
Gurgoglione, F. L., Gregorio, M. D., Benatti, G., Donelli, D., Vignali, L., Solinas, E., Tadonio, I., Denegri, A., Covani, M., Dallaglio, G., et al. (2024) · Future Pharmacology · doi:10.3390/futurepharmacol4040041 · Cited by 26
Cardiovascular disease in the World Trade Center Health Program General Responder Cohort
Sloan, N. L., Shapiro, M. Z., Sabra, A., Dasaro, C. R., Crane, M. A., Harrison, D. J., Luft, B. J., Moline, J. M., Udasin, I. G., Todd, A. C., et al. (2020) · American Journal of Industrial Medicine · doi:10.1002/ajim.23207 · Cited by 26
Xue, P., Lin, L., Li, P., Cheng, S., Chen, D., Fan, M., Zhuang, Y., & Chen, X. (2025) · BMC Public Health · doi:10.1186/s12889-025-22193-6 · Cited by 25
Advancing the Culture of Patient Safety and Quality ImprovementCME
MacGillivray, T. E. (2020) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-16-3-192 · Cited by 35
Willemink, M. J., Varga‐Szemes, Á., Schoepf, U. J., Codari, M., Nieman, K., Fleischmann, D., & Mastrodicasa, D. (2021) · European Radiology Experimental · doi:10.1186/s41747-021-00207-3 · Cited by 25
Zhang, L., Wilson, J. P., Zhao, N., Zhang, W., & Wu, Y. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156951 · Cited by 29
Kawasaki, T., Kidoh, M., Kido, T., Sueta, D., Fujimoto, S., Kumamaru, K. K., Uetani, T., Tanabe, Y., Ueda, T., Sakabe, D., et al. (2020) · Academic Radiology · doi:10.1016/j.acra.2019.12.013 · Cited by 25
Imahori, Y., Vetrano, D. L., Ljungman, P. L. S., Laukka, E. J., Wu, J., Grande, G., Rizzuto, D., Fratiglioni, L., & Qiu, C. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13114 · Cited by 24
PEG-modified nano liposomes co-deliver Apigenin and RAGE-siRNA to protect myocardial ischemia injury
Liu, C., Zhang, X., Yang, H., Zhao, M., Liu, Y., Zhao, R., Li, Z., & Sun, M. J. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123673 · Cited by 25
SPTLC3 Is Essential for Complex I Activity and Contributes to Ischemic Cardiomyopathy
Kovilakath, A., Mauro, A. G., Valentine, Y. A., Raucci, F. J., Jamil, M., Carter, C., Thompson, J., Chen, Q., Beutner, G., Yang, Y., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.066879 · Cited by 24
Zhang, C., Chang, X., Zhao, D., He, Y., Dong, G., & Gao, L. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101051 · Cited by 26
“Ischemic heart disease (IHD) is a cardiovascular condition and a leading cause of morbidity and mortality [1].”
Yang, P.-X., Fan, X., Liu, M., Zhang, X.-Z., Cao, L., Wang, Z., Tian, J., Yong-wen, Z., & Xiao, W. L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155993 · Cited by 26
Zhang, H., Liu, L., Shen, C., Jiang, X., Liu, J., Chen, J., Xu, S.-L., & Mo, Y. (2025) · Research · doi:10.34133/research.0705 · Cited by 24
Tagami, T., Almahariq, M. F., Balanescu, D. V., Quinn, T. J., Dilworth, J. T., Franklin, B. A., & Bilolikar, A. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.038 · Cited by 26
Aboulgheit, A., Potz, B. A., Scrimgeour, L. A., Karbasiafshar, C., Shi, G., Zhang, Z., Machan, J. T., Schorl, C., Brodsky, A. S., Braga, K. M. D. S., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.017437 · Cited by 24
Daralammouri, Y., Nazzal, Z. A. S., Mosleh, Y. S., Abdulhaq, H. K., Khayyat, Z. Y., Hamshary, Y. E., Azamtta, M., Ghanim, A., Awwad, F., Majadla, S., et al. (2022) · Journal of Interventional Cardiology · doi:10.1155/2022/7698583 · Cited by 24
“Ischemic heart disease (IHD) is the leading cause of death globally [1].”
BackgroundSex Differences in Cardiovascular Outcomes of Older Adults After Myocardial Infarction
Kerola, A. M., Palomäki, A., Rautava, P. T., Nuotio, M. S., & Kytö, V. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022883 · Cited by 23
Gaballah, M., Penttinen, K., Kreutzer, J., Mäki, A.-J., Kallio, P. J., & Aalto‐Setälä, K. (2022) · Cells · doi:10.3390/cells11061045 · Cited by 23
Su, X., Zhou, M., Li, Y., An, N., Yang, F., Zhang, G., Xu, L., Chen, H., Wu, H., & Xing, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8726564 · Cited by 24
“IHD remains one of the leading causes of death among cardiovascular diseases, which brings huge social and economic burden [2, 3].”
BackgroundApaydın, O., Altaikyzy, A., Filosa, A., & Sawamiphak, S. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.09.011 · Cited by 23
Fanta, K., Daba, F. B., Asefa, E. T., Melaku, T., Chelkeba, L., Fekadu, G., & Gudina, E. K. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707700 · Cited by 22
Clair, L., Anderson, H. D., Anderson, C. M., Ekuma, O., & Prior, H. J. (2022) · Canadian Journal of Public Health · doi:10.17269/s41997-021-00589-2 · Cited by 24
Short review on the use of graphene as a biomaterial –prospects, and challenges in Brazil
Souza, I. E. P. E., Cambraia, L. V., Gomide, V. S., & Nunes, E. H. M. (2022) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2022.05.170 · Cited by 22
Ramírez, J., van Duijvenboden, S., Young, W. J., Tinker, A., Lambiase, P. D., Orini, M., & Munroe, P. B. (2022) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.121.003441 · Cited by 23
Tang, X., Nishimura, A., Ariyoshi, K., Nishiyama, K., Kato, Y., Васильева, Е. А., Mishchenko, N. P., Fedoreyev, S. A., Stonik, V. A., Kim, H. K., et al. (2023) · Marine Drugs · doi:10.3390/md21010052 · Cited by 22
Gaete, P. V., Nieves-Barreto, L. D., Guatibonza-García, V., Losada-Barragán, M., Vargas-Sánchez, K., & Mendivil, C. O. (2023) · Scientific Reports · doi:10.1038/s41598-023-38700-x · Cited by 22
Oskuye, Z. Z., Mehri, K., Mokhtari, B., Bafadam, S., Nemati, S., & Badalzadeh, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28158 · Cited by 22
Will the plant-based movement redefine physicians’ understanding of chronic disease?
Storz, M. A. (2020) · The New Bioethics · doi:10.1080/20502877.2020.1767921 · Cited by 22
“Heart disease remains the single largest cause of death in countries of all income groups (Nowbar et al. 2019).”
BackgroundAshish, L., Kumar, S., V, & Yeligeti, S. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.01.715 · Cited by 22
RetractedNorland, K., Schaid, D. J., Naderian, M., Na, J., & Kullo, I. J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.052 · Cited by 21
Triggers, Types, and Treatments for Kounis Syndrome: A Systematic Review
PÉREZ, E., Santaularia-Tomas, M., Martin-Dorantes, M. A., Villarreal-Jimenez, E., Olivera-Mar, A., Sanchez-Felix, E., Pérez-Navarrete, A., Millet-Herrera, J. L., Huchim-Mendez, O., Alejos-Briceño, R., et al. (2025) · Clinics and Practice · doi:10.3390/clinpract15030059 · Cited by 21
“There is a need for prospective and multicenter studies from every geographical region to ultimately develop guides and recommendations that consider the variability of human groups.”
Wei, H., Wang, C., Guo, R., Takahashi, K., & Naruse, K. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.119 · Cited by 21
Barbu, M. G., Thompson, R. J., Thompson, D. C., Crețoiu, D., & Suciu, N. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.567199 · Cited by 21
“Even though their mortality has progressively decreased over the last years in Western countries, thanks to the advancements in primary prevention and the improvement of diagnosis and treatment, they still represent a significant burden for developing countries (45).”
BackgroundCircular RNAs as a Diagnostic and Therapeutic Target in Cardiovascular Diseases
Joaquim, V. H. A., Pereira, N. P., Fernandes, T. M., & de Oliveira, E. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032125 · Cited by 21
“Additionally, known as coronary heart disease or even ischemic heart disease, coronary artery disease (CAD) is characterized by atherosclerotic occlusions of the coronary arteries, possibly leading to myocardial infarction and sudden death, and it is the primary cause of death worldwide [77,78].”
BackgroundWéber, A., Laversanne, M., Nagy, P., Kenessey, I., Soerjomataram, I., & Bray, F. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-01039-8 · Cited by 23
Raffee, L. A., Alawneh, K. Z., Ibdah, R., Rawashdeh, S., Zoghoul, S. B. M., Ewais, A. S., & Al-Mistarehi, A.-H. W. (2020) · Open Access Emergency Medicine · doi:10.2147/oaem.s272961 · Cited by 21
Stătescu, C., Clément, A., Șerban, I.-L., & Sascău, R. A. (2021) · Nutrients · doi:10.3390/nu13041076 · Cited by 22
Increased A-to-I RNA editing in atherosclerosis and cardiomyopathies
Mann, T. D., Kopel, E., Eisenberg, E., & Levanon, E. Y. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010923 · Cited by 20
“atherosclerotic-related diseases such as ischemic heart disease (IHD) and cardiomyopathy (ICM), are the most common causes of morbidity and mortality in the western world [17].”
BackgroundCao, Q., Liu, L., Hu, Y., Cao, S., Tan, T., Huang, X., Deng, Q., Chen, J., Guo, R., & Zhou, Q. S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1248056 · Cited by 20
“With the progress of population aging in the past few decades, the prevalence of ischemic heart disease has reached pandemic levels and has resulted in a sharp increase in mortality and morbidity worldwide (3, 4).”
BackgroundEffect of a 6-week and 12-week cardiac rehabilitation program on heart rate recovery
Missiri, A. E., Amin, S. A., Tawfik, I. R., & Shabana, A. M. (2020) · The Egyptian Heart Journal · doi:10.1186/s43044-020-00107-8 · Cited by 21
Liu, C., Li, B., Yan, Q., Niu, S., Zhao, Y., Xiong, C., Zhang, T., & Wei, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6632813 · Cited by 20
Pal, P., & Mahadevappa, M. (2022) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2022.3184656 · Cited by 20
Panteris, E., Deda, O., Papazoglou, Α. S., Karagiannidis, E., Liapikos, T., Begou, O., Meikopoulos, T., Mouskeftara, T., Sofidis, G., Sianos, G., et al. (2022) · Metabolites · doi:10.3390/metabo12090816 · Cited by 20
Therapeutic potential for P2Y2 receptor antagonism
Jasmer, K. J., Forti, K. M., Woods, L. T., Cha, S., & Weisman, G. A. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09900-3 · Cited by 21
Anokye, R., Jackson, B., Dimmock, J. A., Dickson, J. M., Kennedy, M. A., Schultz, C. J., Blekkenhorst, L. C., Hodgson, J. M., Stanley, M. J., & Lewis, J. R. (2023) · Health Promotion International · doi:10.1093/heapro/daad040 · Cited by 20
Jeong, S., Park, B., Kim, J., Lee, S., You, H., Lee, J. H., Lee, S. O., Park, J.-H., Kim, J., Sim, W., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02410-x · Cited by 22
Yagel, O., Shadafny, N., Eliaz, R., Dagan, G., Leibowitz, D. W., Tahiroglu, I., Planer, D., Amir, O., Elbaz‐Greener, G., & Alcalai, R. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s298436 · Cited by 19
Hata, Y., Mochizuki, J., Okamoto, S., Matsumi, H., & Hashimoto, K. (2022) · Medicine · doi:10.1097/md.0000000000029875 · Cited by 19
“[1] Coronary artery disease (CAD), the leading cardiovascular (CV) cause of death, is a form of ischemic heart disease characterized by blockage or narrowing (stenosis) of the arteries that supply blood to the heart.”
Kumar, V. R. S., Sundararam, B. R., Radhakrishnan, P. K., Chandrasekaran, N., Choudhary, S. K., Sankar, V., Sukumaran, A., Rajendran, V., Rafic, S. A. R. M., Panchal, D., et al. (2022) · Physics of Fluids · doi:10.1063/5.0105407 · Cited by 19
RetractedGecaite-Stonciene, J., Hughes, B. M., Kažukauskienė, N., Bunevičius, A., Burkauskas, J., Neverauskas, J., Bellani, M., & Mickuviene, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-23712-w · Cited by 16
Campbell, D. J., Francis, V. C. M., Young, G. R., & Woodford, N. W. F. (2024) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.124.037332 · Cited by 17
The Cardiac Injury Immune Response as a Target for Regenerative and Cellular Therapies
Hume, R. D., & Chong, J. J. H. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.09.006 · Cited by 19
DJ-1 attenuates the glycation of mitochondrial complex I and complex III in the post-ischemic heart
Pantner, Y., Polavarapu, R., Chin, L., Li, L., Shimizu, Y., & Calvert, J. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-98722-1 · Cited by 19
Pham, H. N., Ibrahim, R., Sainbayar, E., Olson, A., Singh, A., Khanji, M. Y., Lee, J. Z., Somers, V. K., Wenger, C., Chahal, C. A. A., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.037381 · Cited by 18
Sharafi, M. H., Nazari, A., Cheraghi, M., Souri, F., & Bakhshesh, M. (2025) · Osteoporosis International · doi:10.1007/s00198-025-07553-7 · Cited by 20
Kumar, V. R. S., Choudhary, S. K., Radhakrishnan, P. K., Bharath, R. S., Chandrasekaran, N., Sankar, V., Sukumaran, A., & Oommen, C. (2021) · Global Challenges · doi:10.1002/gch2.202000076 · Cited by 18
RetractedDeep learning applications in myocardial perfusion imaging, a systematic review and meta-analysis
Alskaf, E., Dutta, U., Scannell, C. M., & Chiribiri, A. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.101055 · Cited by 18
“Full Ovid search strategy and output is shown in Appendix [1].”
BackgroundMethodThe grand challenge of discovering new cardiovascular drugs
Hong, C. C. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.1027401 · Cited by 19
“This is despite the fact that, in the developed world, there has been a substantial decline in cardiovascular mortality since the mid-20th century (Centers for Disease Control and Prevention (CDC), 1999), driven largely by a reduction in ischemic heart disease (Mensah et al., 2017; Nowbar et al., 2019).”
BackgroundZhang, J., Yuan, Z., Mo, C., Kang, Y., Wang, F., Wei, X., Huang, S., Qin, F., Jiang, J., Liang, H., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1247705 · Cited by 19
Saleem, M., Masenga, S. K., Ishimwe, J., Demirci, M., Ahmad, T., Jamison, S., Albritton, C. F., Mwesigwa, N., Haynes, A. P., White, J., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.22031 · Cited by 20
Kmiotek‐Wasylewska, K., Łabędź‐Masłowska, A., Bobis‐Wozowicz, S., Karnas, E., Noga, S., Sekuła‐Stryjewska, M., Woźnicka, O., Madeja, Z., Dawn, B., & Zuba‐Surma, E. K. (2024) · The FASEB Journal · doi:10.1096/fj.202301836r · Cited by 18
Yang, J.-J., Zhang, X.-H., Ma, X., Duan, W., Xu, N., Chen, Y., & Liang, L. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.01.009 · Cited by 18
Foldes‐Busque, G., Dionne, C. E., Turcotte, S., Tully, P. J., Tremblay, M.-A., Poirier, P., & Denis, I. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01848-3 · Cited by 20
Transplantation of CD34+ cells for myocardial ischemia
Matta, A. G., Nader, V., Galinier, M., & Roncalli, J. G. (2021) · World Journal of Transplantation · doi:10.5500/wjt.v11.i5.138 · Cited by 18
Effective transcatheter intracoronary delivery of mRNA-lipid nanoparticles targeting the heart
Handa, K., Kawamura, M., Sasai, M., Matsuzaki, T., Harada, A., Fujimura, L., Whitehouse, J., Saito, S., Komukai, S., Kitamura, T., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113623 · Cited by 19
Li, Q., Hamdalla, R. H., Dhyani, N., Sun, L., Gao, L., Rudebush, T., Zucker, I. H., & Tian, C. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.05.002 · Cited by 19
Association between osteosarcopenia and coronary artery calcification in asymptomatic individuals
Park, C., Lee, Y., & Yoon, K. J. (2022) · Scientific Reports · doi:10.1038/s41598-021-02640-1 · Cited by 18
Sahar, W., Waseem, M., Riaz, M., Nazeer, N., Ahmad, M. M., & Haider, Z. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231207795 · Cited by 17
Ouranos, K., Vassilopoulos, S., Vassilopoulos, A., Shehadeh, F., & Mylonakis, E. E. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2497 · Cited by 17
Automated Diagnosis System for Outpatients and Inpatients With Cardiovascular Diseases
Karboub, K., Tabaa, M., Monteiro, F., Dellagi, S., Moutaouakkil, F., & Dandache, A. (2020) · IEEE Sensors Journal · doi:10.1109/jsen.2020.3019668 · Cited by 17
Querio, G., Antoniotti, S., Geddo, F., Tullio, F., Penna, C. R. R., Pagliaro, P., & Gallo, M. P. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106921 · Cited by 17
Hypercholesterolemia Interferes with Induction of miR-125b-1-3p in Preconditioned Hearts
Szabó, M. R., Gáspár, R., Pipicz, M., Zsindely, N., Diószegi, P., Sárközy, M., Bodai, L., & Csont, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113744 · Cited by 17
“Myocardial infarction, characterized by restriction of blood flow to the myocardium, is a major cause of death worldwide [1,2].”
BackgroundTan, Y. T., Bie, Y.-L., Chen, L., Zhao, Y., Song, L., Miao, L., Yu, Y., Chai, H., Ma, X., & Shi, D. (2021) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-021-2881-0 · Cited by 16
Trends in Mortality from Ischemic Heart Disease in the Region of the Americas, 2000–2019
Lanas, F. T., & Soto, Á., V (2022) · Global Heart · doi:10.5334/gh.1144 · Cited by 16
Ahmad, T., Khan, T., Kirabo, A., & Shah, A. J. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45060297 · Cited by 16
“According to world health organization (WHO), IHD is one of the main cause of deaths worldwide, responsible for more than nine million deaths in 2016 [2].”
BackgroundRivera, A., Campos, B., Ceolin, S., Godoi, A., Castanha, E. B., Jorge, C. A. C., & Cardoso, R. N. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad245 · Cited by 17
Bioactive Glass and Silica Particles for Skeletal and Cardiac Muscle Tissue Regeneration
Ege, D., Lu, H.-H., & Boccaccini, A. R. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0277 · Cited by 16
A machine learning approach to cardiovascular disease prediction with advanced feature selection
Abdullahi, A., Barre, M. A., & Elmi, A. H. (2024) · Indonesian Journal of Electrical Engineering and Computer Science · doi:10.11591/ijeecs.v33.i2.pp1030-1041 · Cited by 16
Hormonal control of cardiac regenerative potential
Amram, A. V., Cutie, S., & Huang, G. N. (2020) · Endocrine Connections · doi:10.1530/ec-20-0503 · Cited by 16
Wang, N., Ma, J., Ma, Y., Lu, L., Ma, C., Qin, P., Gao, E., Zuo, M., Yang, J. Z., & Yang, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.629547 · Cited by 16
“Ischemic heart disease is a common cardiovascular problem with high morbidity and mortality (1).”
BackgroundMethodChatGPT Exhibits Gender and Racial Biases in Acute Coronary Syndrome ManagementPreprint
Zhang, A., Yüksekgönül, M., Guild, J., Zou, J., & Wu, J. C. (2023) · medRxiv · doi:10.1101/2023.11.14.23298525 · Cited by 24
Nanoparticles Targeting the Molecular Pathways of Heart Remodeling and Regeneration
Gonciar, D., Mocan, T., & Agoşton-Coldea, L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040711 · Cited by 16
Segmentation-Free PVC for Cardiac SPECT Using a Densely-Connected Multi-Dimensional Dynamic Network
Xie, H., Liu, Z., Shi, L., Greco, K., Chen, X., Zhou, B., Fehér, A., Stendahl, J. C., Boutagy, N. E., Kyriakides, T. C., et al. (2022) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2022.3226604 · Cited by 15
Leal, J. S. V., Vegi, A. S. F., Meireles, A. L., Machado, Í. E., & de Menezes, M. C. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.08.019 · Cited by 15
Ibrahim, R., Salih, M., Tirambulo, C. V. G., Takamatsu, C., Lee, J. Z., Fortuin, D. F., & Lee, K. S. S. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100577 · Cited by 16
You, S., Zhang, H.-F., Zhang, S.-L., Gao, Q.-Y., Cai, Y.-W., Huang, Z.-G., Wu, Y.-B., Chen, Y.-X., Wang, J.-F., Gao, J.-W., et al. (2024) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.123.033043 · Cited by 11
Lymphocyte-based inflammatory markers: Novel predictors of significant coronary artery disease✰,✰✰
Hani, D. A. B., Alshraideh, J. A., Saleh, A., Alduraidi, H., Alwahadneh, A. A., & Al‐Zaiti, S. S. (2024) · Heart & Lung · doi:10.1016/j.hrtlng.2024.11.006 · Cited by 16
Sea surface temperature variability and ischemic heart disease outcomes among older adults
Majeed, H., Moineddin, R., & Booth, G. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-83062-x · Cited by 16
Hani, S. B., & Ahmad, M. M. (2023) · JMIR Cardio · doi:10.2196/48795 · Cited by 15
“Furthermore, new issues had emerged in transitional countries as a result of globalization, which increased risk factors and sedentary lifestyle adoption, having sharply increased cardiovascular mortality rates [7].”
BackgroundThe effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes
Argan, O., Çıkrıkçı, K., Baltacı, A., & Gençer, N. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1781844 · Cited by 15
Çelik, Y., Thunström, E. Ö., Strollo, P. J., & Peker, Y. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.11.034 · Cited by 15
Metadata
- Authors
- Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P., & Al-Lamee, R.
- Affiliations
- Hammersmith Hospital (GB)
- International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom (A.N.N., M.G., J.P.H., D.P.F., R.A.-L.).
- Corresponding author
- Nowbar, Alexandra N.
- Venue
- Circulation: Cardiovascular Quality and Outcomes
- Published
- 2019-06
- Volume
- 12
- Issue
- 6
- Pages
- e005375-e005375
- ISSN
- 1941-7705 (ISSN-L)
- 1941-7713
- PMC
- PMC6613716
- OpenAlex
- W2950663303
- Cited by
- 860
- References
- 20
- Citations by year
- 2026: 58 · 2025: 121 · 2024: 149 · 2023: 155 · 2022: 147 · 2021: 133 · 2020: 83 · 2019: 12
- FWCI
- 71.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Circulation Cardiovascular Quality and Outcomes (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (212183/Z/18/Z)
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Keywords
- ischemic heart disease, mortality trends, age-standardized mortality rates, non-communicable diseases, lung cancer, stroke, cardiovascular risk factors, smoking, hypertension, obesity, type 2 diabetes, income inequality, sex differences, global burden of disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Risk Factors, Smoking, Time Factors, Global Health, World Health Organization, Comorbidity, Prevalence, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Health Status Disparities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review